[PHAS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -11.14%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 11 320 2,361 668 0 0 -
PBT -129 -98,565 -39,247 -23,846 -10,247 -9,220 -57.40%
Tax 2 -12,264 1,565 -278 1,014 281 -62.78%
NP -131 -98,565 -39,247 -23,846 -10,247 -9,220 -57.27%
Tax Rate - - - - - - -
Total Cost 142 98,885 41,608 24,514 10,247 9,220 -56.57%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,210.15 -30,801.56 -1,662.30 -3,569.76 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.00 -3.39 -1.43 -4.49 -0.91 -0.74 -
EPS Diluted -0.00 -3.39 -1.43 -4.49 -0.91 -0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.